Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

[Clinical observations in cutan mastocytosis].

Mihalik N, Hidvégi B, Hársing J, Várkonyi J, Csomor J, Kovalszky I, Marschalkó M, Kárpáti S.

Orv Hetil. 2013 Sep 15;154(37):1469-75. doi: 10.1556/OH.2013.29702. Hungarian.

PMID:
24016753
2.

Mastocytosis: state of the art.

Horny HP, Sotlar K, Valent P.

Pathobiology. 2007;74(2):121-32. Review.

PMID:
17587883
3.

Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.

Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.

Leuk Lymphoma. 2003 Feb;44(2):313-9.

PMID:
12688351
4.

Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.

Agarwala MK, George R, Mathews V, Balasubramanian P, Thomas M, Nair S.

J Dermatolog Treat. 2013 Dec;24(6):481-3. doi: 10.3109/09546634.2013.802274. Epub 2013 May 30.

PMID:
23659595
5.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Álvarez-Twose I, Jara-Acevedo M, Morgado JM, García-Montero A, Sánchez-Muñoz L, Teodósio C, Matito A, Mayado A, Caldas C, Mollejo M, Orfao A, Escribano L.

J Allergy Clin Immunol. 2016 Jan;137(1):168-78.e1. doi: 10.1016/j.jaci.2015.05.008. Epub 2015 Jun 19.

PMID:
26100086
6.

Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.

Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K.

Mod Pathol. 2014 Jan;27(1):19-29. doi: 10.1038/modpathol.2013.117. Epub 2013 Jun 28.

7.

Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.

Horny HP, Sotlar K, Valent P.

Pathobiology. 2010;77(4):169-80. doi: 10.1159/000305552. Epub 2010 Jul 7. Review.

PMID:
20616612
8.

Mastocytosis and related disorders.

Chiu A, Orazi A.

Semin Diagn Pathol. 2012 Feb;29(1):19-30. Review.

PMID:
22372203
9.

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.

Int Arch Allergy Immunol. 2014;165(2):104-10. doi: 10.1159/000368799. Epub 2014 Nov 15.

PMID:
25402852
10.

[Systemic mastocytosis].

Niedoszytko M, Lange M, Chelminska M, Jaśkiewicz K, Piskosz A, Wasag B, Lewandowski K, Mital A, Renke J, Gruchała-Niedoszytko M, Woźniak M, Babińska A, Jassem E.

Pneumonol Alergol Pol. 2005;73(3):239-44. Polish.

PMID:
16989160
11.

Successful treatment of KIT D816V-positive, imatinib-resistant systemic mastocytosis with interferon-alpha.

Yoshida C, Takeuchi M, Tsuchiyama J, Sadahira Y.

Intern Med. 2009;48(22):1973-8. Epub 2009 Nov 16.

12.

TMEP or not TMEP: That is the question.

Marrouche N, Grattan C.

J Am Acad Dermatol. 2014 Mar;70(3):581-2. doi: 10.1016/j.jaad.2013.09.006. No abstract available.

PMID:
24528906
13.

Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.

Severino M, Chandesris MO, Barete S, Tournier E, Sans B, Laurent C, Apoil PA, Lamant L, Mailhol C, Laroche M, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C.

J Am Acad Dermatol. 2016 May;74(5):885-91.e1. doi: 10.1016/j.jaad.2015.10.050. Epub 2016 Feb 19.

PMID:
26899198
14.

[Mastocytosis].

Barete S.

Ann Dermatol Venereol. 2014 Nov;141(11):698-714; quiz 697, 715. doi: 10.1016/j.annder.2014.08.002. Epub 2014 Oct 16. Review. French. No abstract available.

PMID:
25442476
15.

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB; Mastocytosis Centre Odense University Hospital (MastOUH)..

Eur J Haematol. 2012 Jul;89(1):42-6. doi: 10.1111/j.1600-0609.2012.01789.x. Epub 2012 Apr 28.

PMID:
22469616
16.

Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.

Gutiérrez-González E, Ginarte M, Toribio J.

Dermatol Online J. 2011 Nov 15;17(11):15.

17.

The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.

De Matteis G, Zanotti R, Colarossi S, De Benedittis C, Garcia-Montero A, Bonifacio M, Sartori M, Aprili F, Caruso B, Paviati E, Carli G, Perbellini O, Zamò A, Bonadonna P, Pizzolo G, Guidi G, Martinelli G, Soverini S.

Leuk Res. 2015 Mar;39(3):273-8. doi: 10.1016/j.leukres.2014.11.029. Epub 2014 Dec 6.

PMID:
25582384
18.

Mastocytosis.

Abid A, Malone MA, Curci K.

Prim Care. 2016 Sep;43(3):505-18. doi: 10.1016/j.pop.2016.04.007. Review.

PMID:
27545739
19.

Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.

Wimazal F, Schwarzmeier J, Sotlar K, Simonitsch I, Sperr WR, Fritsche-Polanz R, Födinger M, Schubert J, Horny HP, Valent P.

Leuk Lymphoma. 2004 Apr;45(4):723-9.

PMID:
15160946
20.

Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.

Lesnoni La Parola I, Cannistraci C, Izzi S, Pisani F, Amantea A, Rongioletti F.

Int J Dermatol. 2014 Oct;53(10):1265-8. doi: 10.1111/ijd.12182. Epub 2014 Apr 16. No abstract available.

PMID:
24738598

Supplemental Content

Support Center